These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 30489200)

  • 1. Preclinical Evaluation of a New Hydroxypropyl-Guar Phospholipid Nanoemulsion-Based Artificial Tear Formulation in Models of Corneal Epithelium.
    Rangarajan R; Ketelson H
    J Ocul Pharmacol Ther; 2019; 35(1):32-37. PubMed ID: 30489200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-clinical investigation of the efficacy of an artificial tear solution containing hydroxypropyl-guar as a gelling agent.
    Ubels JL; Clousing DP; Van Haitsma TA; Hong BS; Stauffer P; Asgharian B; Meadows D
    Curr Eye Res; 2004 Jun; 28(6):437-44. PubMed ID: 15512952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a Hyaluronic Acid/Hydroxypropyl Guar Artificial Tear Solution on Protection, Recovery, and Lubricity in Models of Corneal Epithelium.
    Rangarajan R; Kraybill B; Ogundele A; Ketelson HA
    J Ocul Pharmacol Ther; 2015 Oct; 31(8):491-7. PubMed ID: 26067908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of hydroxypropyl-guar nanoemulsion on signs and symptoms of dry eye.
    Markoulli M; Wong K; Jia T; Siddireddy JS; Briggs N; Tan J
    Cont Lens Anterior Eye; 2022 Dec; 45(6):101736. PubMed ID: 35835650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propylene Glycol and Hydroxypropyl Guar Nanoemulsion - Safe and Effective Lubricant Eye Drops in the Management of Dry Eye Disease.
    Srinivasan S; Williams R
    Clin Ophthalmol; 2022; 16():3311-3326. PubMed ID: 36237486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safe and Effective Management of Dry Eye Symptoms with Hydroxypropyl Guar and Hyaluronic Acid Dual-Polymer Lubricating Eye Drops: A Review of Preclinical and Clinical Studies.
    Srinivasan S; Garofalo R; Williams R
    Clin Ophthalmol; 2023; 17():3883-3898. PubMed ID: 38105908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective, randomized, controlled comparison of SYSTANE UD eye drops versus VISINE INTENSIV 1% EDO eye drops for the treatment of moderate dry eye.
    Jacobi C; Kruse FE; Cursiefen C
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):598-603. PubMed ID: 22813209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Potential for use of hydroxypropyl guar in tear substitute therapy].
    Brzhesky VV; Golubev SY
    Vestn Oftalmol; 2017; 133(1):88-96. PubMed ID: 28291206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Decade of Effective Dry Eye Disease Management with Systane Ultra (Polyethylene Glycol/Propylene Glycol with Hydroxypropyl Guar) Lubricant Eye Drops.
    Srinivasan S; Manoj V
    Clin Ophthalmol; 2021; 15():2421-2435. PubMed ID: 34135570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of artificial tear treatment on corneal epithelial thickness and corneal topography findings in dry eye patients.
    Çakır B; Doğan E; Çelik E; Babashli T; Uçak T; Alagöz G
    J Fr Ophtalmol; 2018 May; 41(5):407-411. PubMed ID: 29776765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reduction of corneal permeability in patients treated with HP-guar: a fluorophotometric study].
    Cerván-López I; Sáenz-Francés-San-Baldomero F; Benítez-Del-Castillo JM; García-Sánchez J
    Arch Soc Esp Oftalmol; 2006 Jun; 81(6):327-32. PubMed ID: 16804776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of polyethylene glycol-propylene glycol-based lubricant eye drops in reducing squamous metaplasia in patients with dry eye disease.
    Aguilar A; Berra M; Trédicce J; Berra A
    Clin Ophthalmol; 2018; 12():1237-1243. PubMed ID: 30034217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel hydroxypropyl-guar gellable lubricant eye drops for treatment of dry eye.
    Springs CL
    Adv Ther; 2010 Oct; 27(10):681-90. PubMed ID: 20803266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Tolerability of Overdosed Artificial Tears by Abraded Rabbit Corneas.
    Daull P; Raymond E; Feraille L; Garrigue JS
    J Ocul Pharmacol Ther; 2018 Dec; 34(10):670-676. PubMed ID: 30312113
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of different treatment modalities on the efficacy of hydroxypropyl Guar (HP-Guar) formulation on tear film stability (TFS) in subjects exposed to adverse environmental conditions.
    Abusharha A; Pearce IE; Afsar T; Alsaqr A; Fagehi R; Razak S
    BMC Ophthalmol; 2023 May; 23(1):226. PubMed ID: 37211592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protecting the ocular surface and improving the quality of life of dry eye patients: a study of the efficacy of an HP-guar containing ocular lubricant in a population of dry eye patients.
    Rolando M; Autori S; Badino F; Barabino S
    J Ocul Pharmacol Ther; 2009 Jun; 25(3):271-8. PubMed ID: 19366323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open-label evaluation of HP-Guar gellable lubricant eye drops for the improvement of dry eye signs and symptoms in a moderate dry eye adult population.
    Hartstein I; Khwarg S; Przydryga J
    Curr Med Res Opin; 2005 Feb; 21(2):255-60. PubMed ID: 15801996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the Anti-Inflammatory Effects of Artificial Tears in a Rat Model of Corneal Scraping.
    Daull P; Feraille L; Elena PP; Garrigue JS
    J Ocul Pharmacol Ther; 2016 Mar; 32(2):109-18. PubMed ID: 26751507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine A eyedrops with self-nanoemulsifying drug delivery systems have improved physicochemical properties and efficacy against dry eye disease in a murine dry eye model.
    Bang SP; Yeon CY; Adhikari N; Neupane S; Kim H; Lee DC; Son MJ; Lee HG; Kim JY; Jun JH
    PLoS One; 2019; 14(11):e0224805. PubMed ID: 31738791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of HLA-DR in dry eye patients following 30 days of treatment with a lubricant eyedrop solution.
    Fernandez KB; Epstein SP; Raynor GS; Sheyman AT; Massingale ML; Dentone PG; Landegger LD; Asbell PA
    Clin Ophthalmol; 2015; 9():1137-45. PubMed ID: 26170605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.